Human Genome Epidemiology Literature Finder
Records 1 - 8 (of 8 Records) |
Query Trace: Hypersensitivity and BRCA1[original query] |
---|
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. International journal of cancer 2002 1 97 (5): 557-61. Buchholz Thomas A, Wu Xifeng, Hussain Abu, Tucker Susan L, Mills Gordon B, Haffty Bruce, Bergh Sherry, Story Michael, Geara Fady B, Brock William |
Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition. Carcinogenesis 2009 Nov 30 (11): 1898-902. García María J, Fernández Victoria, Osorio Ana, Barroso Alicia, Fernández Fernando, Urioste Miguel, Benítez Javi |
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions. British journal of cancer 2013 Aug 109 (4): 1072-8. Moon D H, Lee J-M, Noonan A M, Annunziata C M, Minasian L, Houston N, Hays J L, Kohn E |
AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia. Human molecular genetics 2015 Sep 24 (18): 5093-108. Virts Elizabeth L, Jankowska Anna, Mackay Craig, Glaas Marcel F, Wiek Constanze, Kelich Stephanie L, Lottmann Nadine, Kennedy Felicia M, Marchal Christophe, Lehnert Erik, Scharf Rüdiger E, Dufour Carlo, Lanciotti Marina, Farruggia Piero, Santoro Alessandra, Savasan Süreyya, Scheckenbach Kathrin, Schipper Jörg, Wagenmann Martin, Lewis Todd, Leffak Michael, Farlow Janice L, Foroud Tatiana M, Honisch Ellen, Niederacher Dieter, Chakraborty Sujata C, Vance Gail H, Pruss Dmitry, Timms Kirsten M, Lanchbury Jerry S, Alpi Arno F, Hanenberg Helm |
Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer. Journal of cancer research and clinical oncology 2018 9 144 (12): 2449-2456. Altwerger Gary, Florsheim Esther B, Menderes Gulden, Black Jonathan, Schwab Carlton, Gressel Gregory M, Nelson Wendelin K, Carusillo Nina, Passante Terri, Huang Gloria, Litkouhi Babak, Azodi Masoud, Silasi Dan-Arin, Santin Alessandro, Schwartz Peter E, Ratner Elena |
Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biological procedures online 2020 10 22 23. Sadeghi Fatemeh, Asgari Marzieh, Matloubi Mojdeh, Ranjbar Maral, Karkhaneh Yousefi Nahid, Azari Tahereh, Zaki-Dizaji Maj |
Predictive factors for carboplatin hypersensitivity reactions in gynecologic cancers: Effect of BRCA status. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2020 10 27 (7): 1704-1709. Rolfe Melanie, Gegeckas Christine, Turner Suzanne, Orr James |
Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations. Journal of the advanced practitioner in oncology 2021 1 10 (5): 428-439. Garcia Andrew, Frahm Corey, Jeter Joanne M, Abraham Ivo, Chambers Setsuko K, Cragun Janiel M, McBride A |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: